Nixon Peabody Trust CO Novartis Ag Transaction History

Nixon Peabody Trust CO

  • $1.18 Billion
  • Q3 2024

A detailed history of Nixon Peabody Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Nixon Peabody Trust CO holds 121,770 shares of NVS stock, worth $12 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares
121,770
Previous 120,476 1.07%
Holding current value
$12 Million
Previous $12.8 Million 9.2%
% of portfolio
1.19%
Previous 1.16%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$106.13 - $120.89 $137,332 - $156,431
1,294 Added 1.07%
121,770 $14 Million
Q2 2024

Jul 26, 2024
SELL
$92.57 - $107.37 $445,446 - $516,664
-4,812 Reduced 3.84%
120,476 $12.8 Million
Q1 2024

May 07, 2024
BUY
$95.27 - $108.47 $384,033 - $437,242
4,031 Added 3.32%
125,288 $12.1 Million
Q4 2023

Feb 09, 2024
BUY
$92.27 - $101.54 $9.4 Million - $10.3 Million
101,925 Added 527.23%
121,257 $12.2 Million
Q3 2023

Oct 23, 2023
SELL
$94.73 - $105.13 $51,627 - $57,295
-545 Reduced 2.74%
19,332 $1.97 Million
Q2 2023

Jul 27, 2023
SELL
$92.52 - $104.91 $476,200 - $539,971
-5,147 Reduced 20.57%
19,877 $2.01 Million
Q1 2023

May 12, 2023
BUY
$80.03 - $92.81 $281,465 - $326,412
3,517 Added 16.35%
25,024 $2.3 Million
Q4 2022

Feb 08, 2023
BUY
$75.55 - $92.52 $668,919 - $819,172
8,854 Added 69.98%
21,507 $1.95 Million
Q3 2022

Mar 15, 2023
BUY
$74.61 - $87.26 $4,476 - $5,235
60 Added 0.28%
21,567 $1.64 Million
Q3 2022

Nov 09, 2022
SELL
$74.61 - $87.26 $1.72 Million - $2.01 Million
-23,063 Reduced 64.57%
12,653 $962,000
Q2 2022

Aug 11, 2022
SELL
$80.52 - $93.75 $810,836 - $944,062
-10,070 Reduced 21.99%
35,716 $3.02 Million
Q1 2022

May 13, 2022
SELL
$80.11 - $90.62 $473,610 - $535,745
-5,912 Reduced 11.44%
45,786 $4.02 Million
Q4 2021

Feb 08, 2022
BUY
$79.7 - $88.13 $281,181 - $310,922
3,528 Added 7.32%
51,698 $4.52 Million
Q3 2021

Nov 04, 2021
BUY
$81.78 - $95.14 $153,501 - $178,577
1,877 Added 4.05%
48,170 $3.94 Million
Q2 2021

Jul 30, 2021
BUY
$85.24 - $94.15 $198,438 - $219,181
2,328 Added 5.3%
46,293 $4.22 Million
Q1 2021

Apr 26, 2021
BUY
$83.5 - $98.47 $4,425 - $5,218
53 Added 0.12%
43,965 $3.76 Million
Q4 2020

Feb 10, 2021
SELL
$78.07 - $94.43 $32,320 - $39,094
-414 Reduced 0.93%
43,912 $4.15 Million
Q3 2020

Nov 03, 2020
BUY
$82.14 - $91.0 $44,355 - $49,140
540 Added 1.23%
44,326 $3.86 Million
Q2 2020

Aug 13, 2020
BUY
$80.93 - $91.1 $50,419 - $56,755
623 Added 1.44%
43,786 $3.83 Million
Q1 2020

Apr 23, 2020
BUY
$70.67 - $99.01 $35,759 - $50,099
506 Added 1.19%
43,163 $3.56 Million
Q4 2019

Jan 24, 2020
BUY
$84.35 - $95.37 $9,700 - $10,967
115 Added 0.27%
42,657 $4.04 Million
Q3 2019

Nov 05, 2019
BUY
$85.54 - $94.26 $170,481 - $187,860
1,993 Added 4.92%
42,542 $3.7 Million
Q2 2019

Aug 01, 2019
BUY
$75.4 - $92.8 $376,773 - $463,721
4,997 Added 14.06%
40,549 $3.7 Million
Q1 2019

Apr 19, 2019
BUY
$75.32 - $86.15 $214,887 - $245,785
2,853 Added 8.73%
35,552 $3.42 Million
Q4 2018

Jan 23, 2019
SELL
$73.66 - $82.02 $38,745 - $43,142
-526 Reduced 1.58%
32,699 $2.81 Million
Q3 2018

Oct 25, 2018
BUY
$66.94 - $77.43 $143,519 - $166,009
2,144 Added 6.9%
33,225 $2.86 Million
Q2 2018

Jul 30, 2018
BUY
$64.91 - $73.36 $157,666 - $178,191
2,429 Added 8.48%
31,081 $2.35 Million
Q1 2018

Apr 27, 2018
BUY
$70.39 - $84.15 $84,116 - $100,559
1,195 Added 4.35%
28,652 $2.32 Million
Q4 2017

Feb 05, 2018
BUY
$72.33 - $77.64 $61,914 - $66,459
856 Added 3.22%
27,457 $2.31 Million
Q3 2017

Nov 01, 2017
BUY
$74.14 - $77.27 $1.97 Million - $2.06 Million
26,601
26,601 $2.28 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Nixon Peabody Trust CO Portfolio

Follow Nixon Peabody Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nixon Peabody Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Nixon Peabody Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email